CLINICAL EVALUATION OF MERATRAN AND FRENQUEL ON A CHRONIC PSYCHOTIC POPULATION
Abstract
Meratran and Frenquel were administered by a double-blind procedure to 63 chronic psychotics whose behavior was rated by psychiatric residents, nurses, and aides. Frenquel produced no significant changes in the rated behavior. Meratran seemed to exacerbate social withdrawal and irresponsibility. Meratran failed to increase the over-all activity level and failed to decrease depressive symptoms. Finally, Meratran had a significant tendency to aggravate perceptual distortion in some patients but also counteracted hallucinatory phenomena and disorientation in a few other patients.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
